Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Mo

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Archivos De Bronconeumologia|January 18, 2025
Clinical Features of Primary Pulmonary Artery Sarcoma: A Systematic Review and Pooled AnalysisFumihiro Kashizaki, Hao Chen, Nanami Tsuchiya, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 28, 2020
A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study)Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, et al.
Phlebology|September 3, 2025
What we cannot miss in clinical trials on compression therapyGiovanni Mosti, Serge Bohbot, Christine Bongards, et al.
International Journal of Cardiology. Heart & Vasculature|June 26, 2026
Retrospective evaluation of Selexipag monotherapy on pulmonary hemodynamics in newly diagnosed, treatment-naïve patients with chronic thromboembolic pulmonary hypertension prior to balloon pulmonary angioplastyNaohiro Komura, Teruyasu Sugano, Toru Suzuki, et al.
Journal of Cardiology|September 12, 2022
Influence of obesity on incidence of thrombosis and disease severity in patients with COVID-19: From the CLOT-COVID studyYoshito Ogihara, Sen Yachi, Makoto Takeyama, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2022
Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Circulation Reports|May 23, 2022
D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan　- From the CLOT-COVID StudyNobutaka Ikeda, Sen Yachi, Makoto Takeyama, et al.
Journal of Epidemiology|November 13, 2022
Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID StudyMakoto Takeyama, Sen Yachi, Yuji Nishimoto, et al.
Thrombosis Research|April 7, 2022
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID studyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Journal of Atherosclerosis and Thrombosis|July 31, 2022
Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Archivos De Bronconeumologia|January 18, 2025
Clinical Features of Primary Pulmonary Artery Sarcoma: A Systematic Review and Pooled AnalysisFumihiro Kashizaki, Hao Chen, Nanami Tsuchiya, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 28, 2020
A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study)Yasuo Okumura, Ikuo Fukuda, Mashio Nakamura, et al.
Phlebology|September 3, 2025
What we cannot miss in clinical trials on compression therapyGiovanni Mosti, Serge Bohbot, Christine Bongards, et al.
International Journal of Cardiology. Heart & Vasculature|June 26, 2026
Retrospective evaluation of Selexipag monotherapy on pulmonary hemodynamics in newly diagnosed, treatment-naïve patients with chronic thromboembolic pulmonary hypertension prior to balloon pulmonary angioplastyNaohiro Komura, Teruyasu Sugano, Toru Suzuki, et al.
Journal of Cardiology|September 12, 2022
Influence of obesity on incidence of thrombosis and disease severity in patients with COVID-19: From the CLOT-COVID studyYoshito Ogihara, Sen Yachi, Makoto Takeyama, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2022
Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Circulation Reports|May 23, 2022
D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan　- From the CLOT-COVID StudyNobutaka Ikeda, Sen Yachi, Makoto Takeyama, et al.
Journal of Epidemiology|November 13, 2022
Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID StudyMakoto Takeyama, Sen Yachi, Yuji Nishimoto, et al.
Thrombosis Research|April 7, 2022
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID studyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Journal of Atherosclerosis and Thrombosis|July 31, 2022
Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID StudyYugo Yamashita, Sen Yachi, Makoto Takeyama, et al.
Pageof 7